Home > News > Asensio Announces Investment Opinion on NVE
April 2nd, 2004
Asensio Announces Investment Opinion on NVE
Today Asensio & Company, Inc., with 12 years of experience as a leading independent equity research firm, published two research reports on NVE Corporation (NASDAQ Symbol: NVEC, $50.83) titled "NVEC fails to solve Cypress' MRAM problems" and "Cypress values NVEC at a maximum of $4.85 per share."
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Graphene industry takes further step towards commercialisation with Haydale IPO listing March 19th, 2014